Stay updated on Pembrolizumab and Lenvatinib in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and Lenvatinib in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and Lenvatinib in Melanoma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    A site-wide banner announces that NIH is transitioning from the term “Artificial Intelligence” to “Super Intelligence” under Executive Order 14434, with links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T19:21:38.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2 while the study page remains a 403 error.
    Difference
    0.2%
    Check dated 2026-10-18T22:40:41.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The footer now identifies the site revision as v3.7.1 instead of v3.7.0.
    Difference
    0.2%
    Check dated 2026-10-11T22:45:25.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    The page now renders a 403 Forbidden error instead of the study content; it shows the standard error screen with navigation and footer, indicating restricted access rather than the original study details.
    Difference
    20%
    Check dated 2026-09-20T22:36:46.000Z thumbnail image
  5. Check
    62 days ago
    Change Detected
    Summary
    An NIH grant/contract attribution (2018) was added to the study's identifiers, and the page now shows Revision: v3.6.6, replacing the previous v3.6.5.
    Difference
    0.0%
    Check dated 2026-08-30T21:53:45.000Z thumbnail image
  6. Check
    83 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.4 to v3.6.5, reflecting a newer iteration of the page content; this is a metadata-level change rather than a substantive update to study details.
    Difference
    0.0%
    Check dated 2026-08-09T07:41:26.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and Lenvatinib in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Lenvatinib in Melanoma Clinical Trial page.